|
|
Profile
|
Delegates :
Hardy T S Kagimoto, MD |
|
Incorporated :
April 11 , 2005 |
Paid in Capital :
100 Million yen |
Employees :
3 人 |
Address :
Collabostation2-604, Maidashi3-1-1, Higashiku, Fukuoka FUKUOKA
〒
|
TEL/FAX :
+81-92-692-6428 / +81-92-642-6428 |
URL：
http://www.aqumen.jp |
Attachment :
|
Mission/Background :
Bring Japanese Cutting edge technology to the global market as de facto standard model. |
|
Technology & Business
|
We have launched our first product all over EU. Recently, we have reached an agreement with Wakamoto pharmaceuticals to accelerate activities in Japan to get the product registered.
|
|
Products & Service
|
Products & Service Name
|
Stage
|
Outline
|
Milestone
|
ILM Blue(BBG250) EU
|
Launched
|
de facto standard technology in EU
|
sales acceleration
|
ILM Blue(BBG250) Japan
|
Phase3
|
discussion with PMDA
|
initiation of P3 in Japan
|
ILM Blue(BBG250) USA
|
Phase3
|
discussion with FDA
|
completion of NDA package
|
|
|
|
|
|
|
|
|
|
Highlights
|
Received Ministry of Economy, Trade and Industry Gold Medal as the best Venture company in 2010
Achievements:1.Invention, 2.Patent Application and Issuance, 3.Approval in EU,4.Completion of Supply Chain in the Global Market,5.Completion of Value Chain in the Global Market
|
|
Hot news
|
We have reached a co-development agreement with Wakamoto Pharmaceuticals to promote BBG250 technology which was invented in Kyushu University. With this alliance we have completed global value chain of this product.
|
|
Alliance strategy
|
not applicable
|
|
|